These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26470764)

  • 1. Intravitreal Dexamethasone Implant for Treatment of Refractory Behçet Posterior Uveitis: One-year Follow-up Results.
    Coşkun E; Celemler P; Kimyon G; Öner V; Kisacik B; Erbagci I; Onat AM
    Ocul Immunol Inflamm; 2015; 23(6):437-43. PubMed ID: 26470764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease.
    Fabiani C; Emmi G; Lopalco G; Vannozzi L; Bacherini D; Guerriero S; Franceschini R; Frediani B; Iannone F; Marco Tosi G; Rigante D; Cantarini L
    Isr Med Assoc J; 2017 Jul; 19(7):415-419. PubMed ID: 28786255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Dexamethasone Implants in Uveitic Macular Edema in Cases with Behçet Disease.
    Yalcinbayir O; Caliskan E; Ucan Gunduz G; Gelisken O; Kaderli B; Yucel AA
    Ophthalmologica; 2019; 241(4):190-194. PubMed ID: 30244248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.
    Lowder C; Belfort R; Lightman S; Foster CS; Robinson MR; Schiffman RM; Li XY; Cui H; Whitcup SM;
    Arch Ophthalmol; 2011 May; 129(5):545-53. PubMed ID: 21220619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of fluocinolone acetonide intravitreal implant in Behçet intractable posterior uveitis.
    Oh EK; Lee EK; Yu HG
    Can J Ophthalmol; 2014 Jun; 49(3):273-8. PubMed ID: 24862774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis.
    Hasanreisoğlu M; Özdemir HB; Özkan K; Yüksel M; Aktaş Z; Atalay HT; Özdek Ş; Gürelik G
    Turk J Ophthalmol; 2019 Oct; 49(5):250-257. PubMed ID: 31650791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis.
    Sella R; Oray M; Friling R; Umar L; Tugal-Tutkun I; Kramer M
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1777-82. PubMed ID: 26228441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcomes in patients with refractory uveitis associated with Behçet disease treated with infliximab.
    Al Rashidi S; Al Fawaz A; Kangave D; Abu El-Asrar AM
    Ocul Immunol Inflamm; 2013 Dec; 21(6):468-74. PubMed ID: 23734940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency.
    Zarranz-Ventura J; Carreño E; Johnston RL; Mohammed Q; Ross AH; Barker C; Fonollosa A; Artaraz J; Pelegrin L; Adan A; Lee RW; Dick AD; Sallam A
    Am J Ophthalmol; 2014 Dec; 158(6):1136-1145.e5. PubMed ID: 25217856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients.
    Markomichelakis N; Delicha E; Masselos S; Sfikakis PP
    Am J Ophthalmol; 2012 Sep; 154(3):534-541.e1. PubMed ID: 22789563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of Treating Pediatric Uveitis With Dexamethasone Implants.
    Tomkins-Netzer O; Talat L; Seguin-Greenstein S; Bar A; Lightman S
    Am J Ophthalmol; 2016 Jan; 161():110-5.e1-2. PubMed ID: 26478217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of dexamethasone intravitreal implant for refractory macular edema in children.
    Lei S; Lam WC
    Can J Ophthalmol; 2015 Jun; 50(3):236-41. PubMed ID: 26040225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone intravitreal implant: an effective adjunctive treatment for recalcitrant noninfectious uveitis.
    Miserocchi E; Modorati G; Pastore MR; Bandello F
    Ophthalmologica; 2012; 228(4):229-33. PubMed ID: 23038070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
    Bae JH; Lee CS; Lee SC
    Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of intravitreal triamcinolone acetonide injection for the treatment of uveitis attacks in Behçet disease.
    Park UC; Park JH; Yu HG
    Ocul Immunol Inflamm; 2014 Feb; 22(1):27-33. PubMed ID: 24063666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
    Khurana RN; Porco TC
    Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
    ; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE
    Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndrome.
    Dutra Medeiros M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3320-4. PubMed ID: 23599334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
    Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
    Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema.
    Callanan DG; Gupta S; Boyer DS; Ciulla TA; Singer MA; Kuppermann BD; Liu CC; Li XY; Hollander DA; Schiffman RM; Whitcup SM;
    Ophthalmology; 2013 Sep; 120(9):1843-51. PubMed ID: 23706947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.